Advanced search
Publication Cover
Leukemia & Lymphoma Volume 42, 2001 - Issue 1-2
Submit an article Journal homepage
128
Views
44
CrossRef citations to date
0
Altmetric
Original Article

The Hypereosinophilic Syndrome Associated with CD4+CD3″ Helper Type 2 (Th2) Lymphocytes

Ilan Bank Department of Medicine, Chaim Sheba Medical Center, Tel-Hashomer; Laboratory for Immunoregulation, Chaim Sheba Medical Center, Tel-HashomerCorrespondence[email protected]
,
Ninette Amariglio Department of Pediatric Hematology-Oncology, Chaim Sheba Medical Center, Tel-Hashomer
,
Avner Reshef Allergy & Immunology Unit, Chaim Sheba Medical Center, Tel-Hashomer
,
Izhar Hardan Department of Pediatric Hematology-Oncology, Chaim Sheba Medical Center, Tel-Hashomer
,
Yizhak Confino Department of Dermatology, Chaim Sheba Medical Center, Tel-Hashomer
,
Henry Trau Department of Dermatology, Chaim Sheba Medical Center, Tel-Hashomer
,
Shmuel Shtrasburg Heller Institute of Medical Research, Chaim Sheba Medical Center, Tel-Hashomer
,
Pnina Langevitz Department of Medicine, Chaim Sheba Medical Center, Tel-Hashomer
,
Yehudith Monselise Immunology Laboratory, Rabin Medical Center, Hadassah Ein Kerem, Israel
,
Meir Shalit Department of Medicine, Hebrew University, Hadassah Ein Kerem, Israel
&
Gideon Rechavi Department of Pediatric Hematology-Oncology, Chaim Sheba Medical Center, Tel-Hashomer
 show all
Pages 123-133 | Published online: 01 Jul 2009

Citations (44)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (5)

Penelope A. McKelvie, Shereen Oon, Evange Romas, Harshal Nandurkar & Constantine S. Tam. (2012) A case of systemic anaplastic lymphoma kinase-negative anaplastic large cell lymphoma associated with hypereosinophilia, granulomatous myositis and vasculitis. Leukemia & Lymphoma 53:11, pages 2279-2282.
Read now
Funda Tekkeşin, Faruk Güçlü Pınarlı, Zühre Kaya, Aynur Oğuz, Ceyda Karadeniz, Arzu Okur & Nalan Akyürek. (2012) High-Risk ALK Negative Anaplastic Large-Cell Lymphoma Presenting with Hypereosinophilic Syndrome in a 2.5-Year-Old Child. Pediatric Hematology and Oncology 29:8, pages 686-690.
Read now
Lawrence B. Schwartz, Javed Sheikh & Anish Singh. (2010) Current strategies in the management of hypereosinophilic syndrome, including mepolizumab. Current Medical Research and Opinion 26:8, pages 1933-1946.
Read now
Miguel L Stein & Marc E Rothenberg. (2005) Hypereosinophilic syndromes and new therapeutic approaches including anti-IL-5. Expert Review of Clinical Immunology 1:4, pages 633-644.
Read now
M. Kadurina, A. Jordanova & S. Tonev. (2004) Syndroma Hypereosinophilicum—Case Report and Review. Biotechnology & Biotechnological Equipment 18:3, pages 156-164.
Read now

Articles from other publishers (39)

Yiyun Shi & Chen Wang. (2022) What we have learned about lymphocytic variant hypereosinophilic syndrome: A systematic literature review. Clinical Immunology 237, pages 108982.
Crossref
Lina Belmesk, Anastasiya Muntyanu, Emmanuelle Cantin, Zeinah AlHalees, Carolyn S. Jack, Michelle Le, Denis Sasseville, Lisa Iannattone, Moshe Ben-Shoshan, Ivan V. Litvinov & Elena Netchiporouk. (2021) Prominent Role of Type 2 Immunity in Skin Diseases: Beyond Atopic Dermatitis. Journal of Cutaneous Medicine and Surgery 26:1, pages 33-49.
Crossref
William Shomali & Jason Gotlib. (2021) World Health Organization‐defined eosinophilic disorders: 2022 update on diagnosis, risk stratification, and management. American Journal of Hematology 97:1, pages 129-148.
Crossref
Jon van der Walt, Attilio Orazi & Daniel A. ArberSa Wang & Roberto Miranda. 2020. Diagnostic Bone Marrow Haematopathology. Diagnostic Bone Marrow Haematopathology 200 230 .
William Shomali & Jason Gotlib. (2019) World Health Organization‐defined eosinophilic disorders: 2019 update on diagnosis, risk stratification, and management. American Journal of Hematology 94:10, pages 1149-1167.
Crossref
Zhihong Hu, Prajwal C. Boddu, Sanam Loghavi, Roberto N. Miranda, Maitrayee Goswami, L. Jeffrey Medeiros, Wayne Tam, Attilio Orazi, Srdan Verstovsek & Sa A. Wang. (2018) A multimodality work-up of patients with Hypereosinophilia. American Journal of Hematology 93:11, pages 1337-1346.
Crossref
Roberto N. Miranda & Sa A. Wang. 2018. Diagnosis of Blood and Bone Marrow Disorders. Diagnosis of Blood and Bone Marrow Disorders 171 193 .
Jason Gotlib. (2017) World Health Organization-defined eosinophilic disorders: 2017 update on diagnosis, risk stratification, and management. American Journal of Hematology 92:11, pages 1243-1259.
Crossref
Soizic Garaud, Florence Roufosse, Pushpamali De Silva, Chunyan Gu-Trantien, Jean-Nicolas Lodewyckx, Hugues Duvillier, Sarah Dedeurwaerder, Martin Bizet, Matthieu Defrance, François Fuks, Françoise Bex & Karen Willard-Gallo. (2017) FOXP1 is a regulator of quiescence in healthy human CD4 + T cells and is constitutively repressed in T cells from patients with lymphoproliferative disorders . European Journal of Immunology 47:1, pages 168-179.
Crossref
Jason Gotlib. 2016. Managing Myeloproliferative Neoplasms. Managing Myeloproliferative Neoplasms 108 119 .
Jason Gotlib. (2015) World Health Organization‐defined eosinophilic disorders: 2015 update on diagnosis, risk stratification, and management. American Journal of Hematology 90:11, pages 1077-1089.
Crossref
Guillaume Lefèvre, Marie-Christine Copin, Delphine Staumont-Sallé, Martine Avenel-Audran, Hélène Aubert, Alain Taieb, Gilles Salles, Hervé Maisonneuve, Kamel Ghomari, Félix Ackerman, Fanny Legrand, André Baruchel, David Launay, Louis Terriou, Christian Leclech, Chahera Khouatra, Chafika Morati-Hafsaoui, Myriam Labalette, Raphäel Borie, François Cotton, Noémie Le Gouellec, Franck Morschhauser, Jacques Trauet, Catherine Roche-Lestienne, Monique Capron, Pierre-Yves Hatron, Lionel Prin & Jean-Emmanuel Kahn. (2014) The Lymphoid Variant of Hypereosinophilic Syndrome. Medicine 93:17, pages 255-266.
Crossref
Tianjiao WangAndrew L. FeldmanDavid A. WadaYe LuAvery PolkRobert BriskiKay RistowThomas M. HabermannDafydd Thomas, Steven C. ZiesmerLinda E. WellikThomas M. Lanigan, Thomas E. WitzigMark R. Pittelkow, Nathanael G. Bailey, Alexandra C. Hristov, Megan S. Lim, Stephen M. AnsellRyan A. Wilcox. (2014) GATA-3 expression identifies a high-risk subset of PTCL, NOS with distinct molecular and clinical features. Blood 123:19, pages 3007-3015.
Crossref
Jason Gotlib. (2014) World Health Organization-defined eosinophilic disorders: 2014 update on diagnosis, risk stratification, and management. American Journal of Hematology 89:3, pages 325-337.
Crossref
N. Savage, T. I. George & J. Gotlib. (2013) Myeloid neoplasms associated with eosinophilia and rearrangement of PDGFRA , PDGFRB , and FGFR1 : a review . International Journal of Laboratory Hematology 35:5, pages 491-500.
Crossref
. 2013. Eosinophils in Health and Disease. Eosinophils in Health and Disease 537 575 .
M. Nicoletti, G. Maccauro, D. Tripodi, A. Saggini, G. Potalivo, M.L. Castellani, F. Conti, M. Rosati, E. Tomato, A. Caraffa, P. Antinolfi, P. Conti & T.C. Theoharides. (2012) Impact of IL-33 on PGD2 Generation by Activated Human Cord Blood-Derived Mast Cell: Lack of Effect on Tryptase Release. European Journal of Inflammation 10:3, pages 473-482.
Crossref
Jason Gotlib. (2012) World Health Organization-defined eosinophilic disorders: 2012 update on diagnosis, risk stratification, and management. American Journal of Hematology 87:9, pages 903-914.
Crossref
Jason Gotlib. (2011) World Health Organization‐defined eosinophilic disorders: 2011 update on diagnosis, risk stratification, and management. American Journal of Hematology 86:8, pages 677-688.
Crossref
Kei Kunimasa, Machiko Arita, Yasuyuki Arai, Kaori Uchino, Masahiro Iwasaku, Tomoyasu Jo, Satoshi Konishi & Tadashi Ishida. (2011) Peripheral T-cell Lymphoma not Otherwise Specified (PTCL-NOS) in a Patient with Hypereosinophilic Syndrome Showing Multiple Nodules on Chest Computed Tomography. Internal Medicine 50:20, pages 2417-2421.
Crossref
Jason Gotlib. 2011. Myeloproliferative Neoplasms. Myeloproliferative Neoplasms 181 203 .
Maria Cristina Rapanotti, Roberta Caruso, Emanuele Ammatuna, Serena Zaza, Laura Trotta, Mariadomenica Divona, Laura Cicconi, Daria Funaro, Giorgio Federici, Sergio Amadori, Giulio De Rossi & Francesco Lo-Coco. (2010) Molecular characterization of paediatric idiopathic hypereosinophilia. British Journal of Haematology 151:5, pages 440-446.
Crossref
G. Helbig, R. Wichary, M. Razny, M. Rodzaj, K. Wozniczka, J. Dziaczkowska-Suszek & S. Kyrcz-Krzemien. (2010) The proportion of CD3− CD4+ T-cell population remained unaffected after corticosteroids treatment for lymphocytic variant hypereosinophilic syndrome (L-HES). Scandinavian Journal of Immunology 72:4, pages 372-373.
Crossref
Hong Liu, Samer Z. Al-Quran & Richard Lottenberg. (2009) Thrombotic storm in Kimura disease. Journal of Thrombosis and Thrombolysis 29:3, pages 354-357.
Crossref
Marie RavoetCatherine SibilleChunyan GuMyriam LibinBenjamin Haibe-Kains, Christos Sotiriou, Michel GoldmanFlorence RoufosseKaren Willard-Gallo. (2009) Molecular profiling of CD3−CD4+ T cells from patients with the lymphocytic variant of hypereosinophilic syndrome reveals targeting of growth control pathways. Blood 114:14, pages 2969-2983.
Crossref
A. Roldán Montaud, M.J. Citores Sánchez, I. Perales Fraile, V. Masip Marzá, C. Bellas Menéndez & J.A. Vargas Núñez. (2009) Variante linfoide del síndrome hipereosinófilo. Revista Clínica Española 209:6, pages 303-308.
Crossref
Gerald J. Gleich & Kristin M. Leiferman. (2009) The hypereosinophilic syndromes: current concepts and treatments. British Journal of Haematology 145:3, pages 271-285.
Crossref
Donald G. GuineeJr.Jr.. 2008. Dail and Hammar’s Pulmonary Pathology. Dail and Hammar’s Pulmonary Pathology 561 599 .
Florence E Roufosse, Michel Goldman & Elie Cogan. (2007) Hypereosinophilic syndromes. Orphanet Journal of Rare Diseases 2:1.
Crossref
Javed Sheikh & Peter F. Weller. (2007) Clinical Overview of Hypereosinophilic Syndromes. Immunology and Allergy Clinics of North America 27:3, pages 333-355.
Crossref
Florence Roufosse, Elie Cogan & Michel Goldman. (2007) Lymphocytic Variant Hypereosinophilic Syndromes. Immunology and Allergy Clinics of North America 27:3, pages 389-413.
Crossref
Elizabeth H. Stover, Jason Gotlib, Jan Cools & D. Gary Gilliland. 2007. Myeloproliferative Disorders. Myeloproliferative Disorders 235 251 .
Jason Gotlib, N.C.P. Cross & D. Gary Gilliland. (2006) Eosinophilic disorders: Molecular pathogenesis, new classification, and modern therapy. Best Practice & Research Clinical Haematology 19:3, pages 535-569.
Crossref
Karen E. Willard-Gallo, Bassam M. Badran, Marie Ravoet, Anne Zerghe, Arsène Burny, Philippe Martiat, Michel Goldman, Florence Roufosse & Catherine Sibille. (2005) Defective CD3γ gene transcription is associated with NFATc2 overexpression in the lymphocytic variant of hypereosinophilic syndrome. Experimental Hematology 33:10, pages 1147-1159.
Crossref
F. Roufosse, E. Cogan & M. Goldman. (2004) Recent advances in pathogenesis and management of hypereosinophilic syndromes. Allergy 59:7, pages 673-689.
Crossref
Animesh Pardanani & Ayalew Tefferi. (2004) Imatinib therapy for hypereosinophilic syndrome and eosinophilia-associated myeloproliferative disorders. Leukemia Research 28, pages 47-52.
Crossref
Jason GotlibJan CoolsJames M. MaloneIIIIIIStanley L. SchrierD. Gary GillilandSteven E. Coutré. (2004) The FIP1L1-PDGFRα fusion tyrosine kinase in hypereosinophilic syndrome and chronic eosinophilic leukemia: implications for diagnosis, classification, and management. Blood 103:8, pages 2879-2891.
Crossref
Florence RoufosseElie CoganMichel Goldman. (2003) The Hypereosinophilic Syndrome Revisited. Annual Review of Medicine 54:1, pages 169-184.
Crossref
Sung‐Eun Chang, Jooryoung Huh, Jee‐Ho Choi, Kyoung‐Jeh Sung, Kee‐Chan Moon & Jai‐Kyoung Koh. (2014) A Case of Hyper‐IgE Syndrome Complicated by Cutaneous, Nodal, and Liver Peripheral T Cell Lymphomas. The Journal of Dermatology 29:5, pages 320-322.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.